WHO ICTRP trial
Comparative bioequivalence study of the Fexofenadine Hydrichloride 180 mg…
IRCT20130313012810N16 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20130313012810N16 |
|---|---|
| Public title | Comparative bioequivalence study of the Fexofenadine Hydrichloride 180 mg, tablet manufactured by Tasnim Company |
| Scientific title | Comparative bioequivalence study of the Fexofenadine Hydrichloride 180 mg, tablet manufactured by Tasnim Company |
| Primary sponsor | Tasnim |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | Bioequivalence |
| Countries | Iran (Islamic Republic of) |
| Conditions | Bioequivalence study in healthy volunteers. |
| Interventions | Intervention group: This study examines the bioequivalence of Fexofenadine tablets produced by a domestic company with a foreign brand sample. We have only one intervention group and there is no control group. The intervention group, which… |
| Registration date | Oct 31, 2023 |
| Target size | 24 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: